-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$17.00161.54% Upside
enGene Holdings Inc. Common Stock Frequently Asked Questions
-
What analysts cover enGene Holdings Inc. Common Stock?
enGene Holdings Inc. Common Stock has been rated by research analysts at Leerink Partners in the past 90 days.